Australia markets closed

Evoke Pharma, Inc. (EV00.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.4380-0.0620 (-12.40%)
At close: 08:12AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 3.73M
Enterprise value 3.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.30
Price/book (mrq)1.72
Enterprise value/revenue 0.77
Enterprise value/EBITDA -0.55

Trading information

Stock price history

Beta (5Y monthly) 0.30
52-week change 3-74.53%
S&P500 52-week change 320.07%
52-week high 32.1400
52-week low 30.4160
50-day moving average 30.5627
200-day moving average 30.9479

Share statistics

Avg vol (3-month) 355
Avg vol (10-day) 3N/A
Shares outstanding 58.48M
Implied shares outstanding 68.52M
Float 84.38M
% held by insiders 19.65%
% held by institutions 129.98%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 324 May 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -150.41%
Operating margin (ttm)-112.64%

Management effectiveness

Return on assets (ttm)-49.09%
Return on equity (ttm)-1,035.44%

Income statement

Revenue (ttm)5.18M
Revenue per share (ttm)1.55
Quarterly revenue growth (yoy)110.50%
Gross profit (ttm)N/A
Net income avi to common (ttm)-7.79M
Diluted EPS (ttm)-2.1900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.74M
Total cash per share (mrq)0.56
Total debt (mrq)5M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.25
Book value per share (mrq)-0.77

Cash flow statement

Operating cash flow (ttm)-4.98M
Levered free cash flow (ttm)-2.53M